Breathing in cancer treatment: new trial tests drug mist for lung tumors
NCT ID NCT03093909
Summary
This early-stage study is testing a new way to give a cancer drug called gemcitabine—by breathing it in as a mist. The main goal is to find the highest safe dose for people whose solid tumors have spread to their lungs. Researchers will also closely monitor side effects and how the body handles the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.